Skip to Main Content

Author Details

David K Edwards
Exact Sciences Corporation
2012
15
8
PMIDPaper TitleJournal TitlePublished Year
36306979The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2023
37152483The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center.Adv Radiat Oncol2023
34391922Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma.Clin Gastroenterol Hepatol2022
32889146A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma.Clin Gastroenterol Hepatol2021
34609947Usability of an At-Home Anterior Nares SARS-CoV-2 RT-PCR Sample Collection Kit: Human Factors Feasibility Study.JMIR Hum Factors2021
32128228Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study).BMJ Open Gastroenterol2020
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
30924767Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells.Elife2019
30720426FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.Elife2019
29567769Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia.Haematologica2018
29872489Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.Oncotarget2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
28630439Recurrent cyclin D2 mutations in myeloid neoplasms.Leukemia2017
28355571Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.Cell Rep2017
22115706Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.Lung Cancer2012
  • 1 - 15 of 15

Recommended Authors

Hopp Children's Cancer Center (KiTZ)
Career Start Year 2017
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 70
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 11
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 5
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 2
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 30
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 6
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 22
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 9
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 1
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 9
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 10
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 3
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 6
McGill University
Career Start Year 1996
Number of shared co-authors 0
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 19
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 26
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 31
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 6

Collaborators

Oregon Health & Science University School of Medicine
Co-authored papers 8
Oregon Health & Science University
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Oregon Health & Science University, University of California Berkeley
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
City of Hope National Medical Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
St Jude Children's Research Hospital.
Co-authored papers 2
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
AbbVie Inc.
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
University of Texas Southwestern Medical Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
University of Utah Huntsman Cancer Institute
Co-authored papers 2
University of Colorado Division of Hematology
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1